Education
About Us
Working with TipRanks
Follow Us
Clinical Laserthermia Systems AB Class B (DE:LS60)
FRANKFURT:LS60
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
LS60 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
€0.82→€1.14
Hold
65.90%
Upside
Reiterated
09/05/25
AI Generated ArticleAI Generated Article
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
€0.82→€1.14
Hold
65.90%
Upside
Reiterated
09/05/25
AI Generated ArticleAI Generated Article
LS60 Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Sep 25
Strong Buy
0
0
0
Buy
0
0
0
Hold
1
6
9
Sell
0
0
0
Strong Sell
0
0
0
total
1
6
9
Each month's total comprises the sum of three months' worth of ratings.
LS60 Stock Forecast FAQ
What is DE:LS60’s average 12-month price target, according to analysts?
Based on analyst ratings, Clinical Laserthermia Systems AB Class B’s 12-month average price target is 1.13.
What is DE:LS60’s upside potential, based on the analysts’ average price target?
Clinical Laserthermia Systems AB Class B has 63.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Clinical Laserthermia Systems AB Class B a Buy, Sell or Hold?
Clinical Laserthermia Systems AB Class B has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Clinical Laserthermia Systems AB Class B’s share price target?
The average share price target for Clinical Laserthermia Systems AB Class B is 1.13. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €1.13 ,and the lowest forecast is €1.13. The average share price target represents 63.77% Increase from the current price of €0.69.
The highest analyst share price target is €1.13 ,and the lowest forecast is €1.13. The average share price target represents 63.77% Increase from the current price of €0.69.
What do analysts say about Clinical Laserthermia Systems AB Class B?
Clinical Laserthermia Systems AB Class B’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Clinical Laserthermia Systems AB Class B?
To buy shares of DE:LS60, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.